Ivoclar Vivadent has just announced the availability of Callisto® CPG, an exciting new entry in controlled price nobel alloys. With a controlled alloy price, laboratories can establish a fixed fee schedule for their PFM or press-to-metal restorations, without being affected by the current precious metal market. Following the same strategy as Callisto CP+, laboratories can continue to benefit from insurance reimbursement for noble alloys provided to patients.
Ivoclar Vivadent has just announced the availability of Callisto® CPG, an exciting new entry in controlled price nobel alloys. With a controlled alloy price, laboratories can establish a fixed fee schedule for their PFM or press-to-metal restorations, without being affected by the current precious metal market. Following the same strategy as Callisto CP+, laboratories can continue to benefit from insurance reimbursement for noble alloys provided to patients.
Callisto® CPG features a low density of 9.3, enabling laboratories to process more units at lower fabrication costs. Callisto® CPG is a cobalt-chrome-based ceramic alloy containing palladium and gold that demonstrates excellent physical properties. With high strength values, it is ideally suited for layering and press techniques.
Callisto® CPG can be used for onlays, crowns, 3/4 crowns, ceramic crowns, short- and long-span bridges, telescope and conus crowns, root canal posts, implant superstructures, partial dentures and model casting. Callisto® CPG is also compatible with the most popular veneering ceramics and is free of silver, copper, nickel and beryllium.
For more information, call 1-800-533-6825 in the U.S., 1-800-263-8182 in Canada.You can also visit www.ivoclarvivadent.com.
How Dentists Can Help Patients Navigate Unforeseen Dental Care
December 12th 2024Practices must equip patients with treatment information and discuss potential financing options before unexpected dental treatments become too big of an obstacle and to help them avoid the risk of more costly and invasive procedures in the future.